Vertically-Integrated Cannabis Brand Captor Capital Ignites Multi-State Expansion

Put Captor Capital Corp on your Radar Immediately
Ticker Symbols (CPTR.CN) in Canada, (CPTRF) on the OTCQX in the US and (NMVA) in Frankfurt

One of the cannabis industry’s best positioned premium seed-to-sale cannabis brands is experiencing a major growth spurt from west to east. And given their recently-released positive $4.4 million in positive EBIDTDA institutional investors may want to take a long, hard look this Company

Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF) is a vertically-integrated, publicly-traded company with a strong cultivation, extraction, brand, and retail footprint that is now a multi-state operation. In short, Captor is capitalizing on expanding.

“Captor has continued to excel and expand our business model. We’ve executed on our mission to acquire positive cash flowing growth business and in the booming Cannabis industry and integrate them under our brand”

John Zorbas, CEO Captor Capital Corp.

Beyond their California home market, Captor Capital Corp. has made strategic moves into Michigan – the second-most populous state in the country to approve recreational marijuana and the first in the Midwest.  The Company recently expanded into Michigan with a partner that has secured critical real estate and coveted limited licenses to cultivate, extract, process, and manufacture in the jurisdiction.

Why Michigan?

Michigan has become the first state, not on the east or west coast, to legalize adult recreational cannabis use. This a huge milestone for the Midwest, but also for the future of the U.S. Here’s why – America’s coast and Midwest might as well be two different countries regarding public opinion. However, cannabis legalization in Michigan signifies a dramatic shift in public opinion…and it’s quickly gone from prohibition to attracting mainstream bipartisan political support.

Company CEO John Zorbas says that Michigan is an attractive state because it has a mature medical cannabis market and has the second-largest medical cannabis patient base in the US, and the largest per capita. Michigan, with a population of 10 million people, has a larger medical cannabis patient base than Canada.

The hard data speaks for itself – Michigan with 313,000 registered medical cannabis patients, or 3.1%, compared to Canada with a population of approximately 38 million, and 296,000 registered medical patients, or 0.77% where cannabis is fully legal at both provincial and federal levels.

Mr. Zorbas believes the company’s experience operating in a highly-competitive market like California makes Captor well-suited to compete in emerging recreational and medical markets.

Here’s what he had to say about this burgeoning market:

“Michigan represents a significant opportunity market with defined barriers to entry at the local level. Our new partner Samona, with an established retail footprint and seasoned and management team will allow us to rapidly expand and scale the Captor brand and presence.”

In a press release from March 27, 2019, the Toronto based company announced they had “signed a binding agreement which provides the Company the right to acquire certain assets to expand operations into Michigan, pending certain regulatory approvals.”

Details of the agreement are as follows:

  • Operation of 20 retail medical cannabis retailers,
  • two licenses to operate a cannabis manufacturing, processing, and extraction facility
  • eight licenses to operate a 325,000 sq. ft. cannabis cultivation facility

Investors should take note that Michigan has the second highest total number of cannabis medical card holders in the United States, second only to California, but uniquely has the highest per capita licensed medical card holders.


Based on our analysis, the 20 dispensaries annual NET income for the first full year of operation could reach close to $18 million.  In addition to that, expectations are for the cannabis cultivation facilities to generate NET income in excess of USD$26 million, bringing the potential total NET income to over USD$44 million.

This is just for the first full year of operation and does not include any possible NET income from the processing licenses.

According to a press release of a research report from CoStar, sales per square foot at most mainstream retailers has declined to an average of around $325 in recent years, down from nearly $375 in the early 2000s.  Marijuana Business Factbook estimates sales per square foot average $1,773 at recreational dispensaries and $1,143 at medical dispensaries, showing they are considerably more profitable per square foot than most mainstream retailers.

Why Captor Capital Corp. ?

Captor’s revenue is expected to exceed a run rate of $45 million, through ownership of top brands and high value dispensary locations.  Aside from the recent Michigan news, Captor already has operations in the highly regarded state of California, with facilities involved in both manufacturing and distribution.  Additionally, Captor has partnerships for cultivation facilities within the state of Washington.

California had total sales of around $2.5 billion of legal cannabis in 2018, which was the first full year of legalized recreational sales.  It appears likely Captor will continue to be active player in the U.S. market as they have collaborated with high profile cannabis companies including MedMen Enterprises Inc. (MMEN.CN).

  • CHAI Santa Cruz – Capitola Healing Association Inc., or CHAI, is an elite medical and recreational cannabis dispensary known for having the highest testing and lowest cost products in Santa Cruz County. Chai Santa Cruz is committed to providing the highest quality 100% LAB-TESTED HIGH-GRADE INDOOR CULTIVATED Medical and Recreational Cannabis. CHAI generated $9 million in revenue for the past three years and was purchased for just $6.1 million. It’s consistently ranked as a top-five dispensary in Santa Cruz, CA, with a large glassware showroom and possesses a license permitting cannabis delivery within the greater Santa Cruz area.  The dispensary brought in about $4.6 million in revenue for the first three quarters of 2018.  CHAI Santa Cruz has top reviews from consumers with a 7 out of 5 star rating on over 500 reviews on
  • CHAI Castroville (former Higher Level Castroville) dispensary has been awarded both state and local licenses to sell recreational cannabis. The licenses were awarded December 10th and the company expects the deal to be finalized shortly. CHAI Castroville is on track to generate approximately $5.5M in gross revenues with adjusted EBITDA of 25% (non IFRS). It is also highly regarded with a 9 out of 5 star rating with over 7,300 reviews on
  • Mellow Extracts, LLC., which will produce ultra-premium oil in a state-of-the-art extraction lab facility in Costa Mesa, California. Mellow will provide service-for-hire extraction, as well as co-packing capacities for white label and private label cannabis brands focusing on cannabis extracts.

Captor management believes strongly in the prospects and future of the company, as evidenced by a press release on Dec 18th 2018 stating they intend to spend up to $5 million buyback and cancel up to 1,967,650 shares of the company’s stock over the next year.

“Captor is commencing the Bid because it believes that the market price of its Shares does not reflect the underlying value of the Company’s business and future prospects,” said Captor Capital CEO, John Zorbas. “

Captor also recently announced Third Quarter Financial Results including operational highlights expected for the calendar year 2019:

  • Launch of CAC’s new E-Commerce delivery business which starts in March 2019.
  • Imminent launch of Mellow Extracts extraction and distribution facility in Costa Mesa.
  • Establishment of the Chai retail brand across all retail stores and the delivery business.
  • Opening of the Goleta, Santa Barbara retail dispensary, subject to regulatory confirmation.
  • Opening of the Chai distribution business in Santa Cruz, subject to regulatory confirmation.
  • CAC’s launch of its self-manufactured and branded cannabis product lines.

Demand for Cannabis and Cannabis derived products are soaring, and governments are adopting legalization, pressure is mounting on the industry to provide all the necessary production and distribution facilities to meet the growing demand.

However, choosing which of these investments to participate in requires more analysis as some stock prices still have room to come down with multiples still in the stratosphere.

Captor Capital should be on your watchlist.


Marijuana is hands down the biggest investment opportunity in the world right now.  No other sector has the potential of making you a multimillionaire faster than this profit loaded industry. Selecting the right stock is not always easy, we suggest you look for value and market penetration in a growing sector.

The Bull Market is just getting started.

[et_bloom_inline optin_id=”optin_6″]


Please read our legal disclaimer below:

Capital Market Review profiles are not a solicitation or recommendation to buy, sell or hold securities. Capital Market Review is a paid advertiser and is not offering securities for sale. Neither Capital Market Review nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by Capital Market Review its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations.

Capital Market Review does not recommend that the securities profiled should be purchased, sold or held and is not liable for any investment decisions by its readers or subscribers.

Information presented by Capital Market Review may contain “forward-looking statements ” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance, are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of words such as “expects, ” “will, ” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating that certain actions “may,” “could,” or “might” occur.




By using Capital Market Review, you agree, without limitation or qualification, to be bound by, and to comply with, these Terms of Use and any other posted guidelines or rules applicable.

The website contains links to other related World Wide Web Internet sites and resources. Capital Market Review is not responsible for the availability of these outside resources, or their contents, nor does Capital Market Review endorse nor is Capital Market Review responsible for any of the contents, advertising, products or other materials on such sites. Under no circumstances shall Capital Market Review be held responsible or liable, directly or indirectly, for any loss or damages caused or alleged to have been caused by use of or reliance on any content, goods or services available on such sites. Any concerns regarding any external link should be directed to its respective site administrator or webmaster.

You agree to indemnify and hold Capital Market Review, its officers, directors, owners, agents and employees, harmless from any claim or demand, including reasonable attorneys fees, made by any third party due to or arising out of your use of the website, the violation of these Terms of Use by you, or the infringement by you, or other user of the website using your computer, of any intellectual property or other right of any person or entity. We reserve the right, at our own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification.

Capital Market Review is owned and operated by Direct Delivery Group LLC, which is a US based limited liability company. We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (this “Article”) about publicly traded companies (the “Profiled Issuers”).

We publish the Information on our website, and in newsletters, text message alerts, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer and / or third party paying us. Our publication of the Information is known as a “Campaign”. This information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. Typically, the trading volume and price of a Profiled Issuer’s securities increases after the information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer trading losses if they purchase the securities of a Profiled Issuer late in a Campaign.

Third Parties paying us to market the Profiled Issuer we believe intend to sell their shares they hold while we tell investors to purchase during the Campaign.

The Information we publish in the Campaign is only a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful and / or reliable. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness and / or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities.

All information in our Campaign is publicly available information from 3rd party sources and / or the Profiled Issuers and/or the 3rd parties that hire us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, Yahoo, Bing, the Securities and Exchange Commission’s Edgar database or other available public sources.

We select the stocks we profile and / or pick as we are compensated to advertise them. If an investor relies solely on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision.

The source of our compensation varies depending upon the particular circumstances of the Campaign. In certain cases, we are compensated by the Profiled Issuers, third party shareholders, and / or other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities.   We are being paid on a CPC – cost per click basis for CPTR.CN.

We make no warranty and / or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation.

We are not, and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following: an independent adviser or consultant; a fortune teller; an investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal and / or state level; a broker-dealer or an individual acting in the capacity of a registered representative or broker; a stock picker; a securities trading expert; a securities researcher or analyst; a financial planner or one who engages in financial planning; a provider of stock recommendations; a provider of advice about buy, sell or hold recommendations as to specific securities; or an agent offering or securities for sale or soliciting their purchase.

There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer.

We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. Third parties that have hired us and own shares will sell these shares while we tell investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.

Our publication of the Information involves actual and material conflicts of interest including but not limited to the fact that we receive monetary compensation in exchange for publishing the (favorable) Information about the Profiled Issuers; and we do not publish any negative information, whatsoever, about the Profiled Issuers; in addition to the fact that while we do not own the Profiled Issuer’s securities, the third parties that hired us do, and intend to sell all of these securities during the Campaign while we publish favorable information that instructs investors to purchase, and this selling of the Profiled Issuer’s securities will likely cause investors to suffer losses.

We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions and / or errors in the Information and we are not responsible for actions taken by any person who relies upon the Information.

We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and / or investment adviser(s). An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products and / or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, Yahoo, Bing, OTC Markets, NASDAQ, NYSE, or other available public sources.

We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose my compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell my own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns.

Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.

We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.

If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.

The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.

The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.

You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.

When 3rd parties that hire us acquire, purchase and / or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit themselves to make substantial profits while investors who purchase during the Campaign experience significant losses.

The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.

We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and may fail to disclose their compensation to you.

If a Profiled Issuer is a SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions.

If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and/or government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies.

The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at, or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at and You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at

Capital Market Review reserves the right, at its sole discretion, to change, modify, add and/ or remove all or part of this Disclaimer and / or Terms of Use at any time.

[et_bloom_inline optin_id=”optin_6″]